What is DSIP?
DSIP stands for Delta Sleep-Inducing Peptide. It is a tiny chain of just nine amino acids — scientists call that a nonapeptide — with a molecular weight of 849 daltons.[4] It was first isolated in 1977 from the cerebral venous blood of rabbits by a Swiss research group, and it quickly attracted attention as a potential natural sleep-promoting substance.[2] Since then, researchers have discovered that DSIP may do a lot more than just nudge an animal toward sleep — it has been studied for roles in stress protection, hormone release, pain, and even withdrawal from certain substances.[3]
Important note: DSIP is a research compound. Everything on this page describes animal and laboratory studies. It is not approved for human use, and nothing here is medical advice.
How DSIP Works
Think of the brain's sleep system like a dimmer switch. Researchers believe DSIP may help turn that switch toward the "deeper sleep" setting rather than simply flipping it on or off. In studies, DSIP has been linked to increases in delta waves — the slow, rolling brainwaves that define deep, restorative sleep — as measured on an EEG (electroencephalogram, the machine that reads electrical activity in the brain).[4]
The exact receptor or gene that DSIP acts on has not been identified, which is one reason scientists still call it an "unresolved riddle."[2] What is clear is that DSIP-like material shows up in the hypothalamus and other brain regions, as well as in peripheral organs and blood plasma of several mammals.[4] Some researchers now think the biological activity attributed to DSIP might actually come from a closely related, not-yet-fully-characterized peptide family.[2]
What the Research Shows
Sleep and brainwave effects
The original research showed DSIP could increase delta sleep in rabbits, rats, mice, and humans, while in cats the effect leaned more toward REM (rapid eye movement) sleep.[4] A 1987 cat study found that a single injection into the brain's lateral ventricle significantly cut the time it took for the animals to fall asleep and boosted total slow-wave sleep — especially the deepest stage (called S2). The increase appeared within the very first hour after injection and lasted up to seven hours.[5] Notably, REM sleep was not changed, suggesting DSIP's action in that study was specific to deep, non-dreaming sleep.[5]
Researchers have also described a curious U-shaped dose-response curve — meaning both the amount of DSIP given and the timing of the infusion mattered enormously. Too little, the right amount, or too much could produce very different results.[4]
Stress and neuroprotection
Beyond sleep, DSIP has been studied for its ability to protect the nervous system under stressful conditions. Animal research noted effects on circadian rhythms, locomotor patterns, neurotransmitter levels, and responses to low-oxygen (hypoxia) conditions.[3] See the dosage chart on this page for the specific doses used in stress and hypoxia protection experiments in rats.
Hormonal effects
A 1987 rat study found that injecting DSIP directly into the brain ventricles stimulated the release of LH (luteinizing hormone) — but only in rats that had been primed with ovarian steroids first. When researchers tested DSIP directly on pituitary tissue in a dish, nothing happened, suggesting the peptide works upstream in the brain's hypothalamic circuitry rather than directly at the pituitary gland.[6] This hints at a possible link between sleep-related signaling and reproductive hormone cycles.
Ongoing uncertainties
Despite decades of research, key questions remain open. No DSIP gene or dedicated receptor has been confirmed.[2] Some structural analogues of DSIP promoted slow-wave sleep in animal studies even when DSIP itself did not, leading researchers to hypothesize that a related, naturally occurring peptide may carry much of the biological activity.[2] A 2001 review noted DSIP's wide range of reported effects while acknowledging that the underlying mechanisms are still not fully understood.[1]
What DSIP Is Being Studied For
- Delta (deep) sleep facilitation and sleep latency reduction[4][5]
- EEG brainwave modulation (delta and sigma wave enhancement)[4]
- Stress response and neuroprotection under hypoxic conditions[3]
- Neuroendocrine signaling, particularly LH release[6]
- Potential roles in pain management and substance withdrawal (early-stage research)[3]
How DSIP Is Dosed in Research
Doses used in published animal studies vary widely depending on the route of administration and the outcome being measured — intracerebroventricular (directly into brain ventricles), intravenous, and intraperitoneal (into the abdominal cavity) routes have all been used, and the numbers look very different across these methods. Rather than restate every figure here, refer to the dosage chart on this page, which lays out each study's route, species, and dose side by side. If you need to convert or scale those figures, the calculator on this page can help. These are strictly research reference points — no human dosing guidance exists or is implied.
Mixing and Storing DSIP
DSIP is typically supplied as a lyophilized powder — that just means it has been freeze-dried for stability. To prepare it for use in research, the powder is reconstituted (dissolved) by adding a small, measured volume of sterile bacteriostatic water or another suitable sterile solvent, then gently swirling (never shaking vigorously) until fully dissolved. Once mixed, the solution should be stored in a refrigerator at 2–8 °C and protected from light. Repeated freeze-thaw cycles degrade peptides, so researchers typically divide reconstituted stock into single-use aliquots (small portions) and freeze what will not be used immediately. Always check the supplier's certificate of analysis and follow standard laboratory sterile technique when handling research peptides.
Sources
- Delta sleep-inducing peptide. — European journal of anaesthesiology, 2001. PMID 11437870.
- Delta sleep-inducing peptide (DSIP): a still unresolved riddle. — Journal of neurochemistry, 2006. PMID 16539679.
- Delta-sleep-inducing peptide (DSIP): an update. — Peptides, 1986. PMID 3550726.
- Delta-sleep-inducing peptide (DSIP): a review. — Neuroscience and biobehavioral reviews, 1984. PMID 6145137.
- The effects of delta-sleep-inducing peptide (DSIP) on wakefulness and sleep patterns in the cat. — Brain research, 1987. PMID 3620931.
- Delta sleep-inducing peptide (DSIP) stimulates LH release in steroid-primed ovariectomized rats. — Life sciences, 1987. PMID 3550343.
EN
BR
ES
FR
DE
RU